Treatment
In the “Golden Age of Eczema,” people with atopic dermatitis have more treatment options than ever before, with even more drugs making their way to pharmacy shelves.
New evidence shows that Lactobacillus-containing probiotic strains may reduce disease severity in children age 3 and under.
Dermatologists discuss the potential efficacy of prescribing an opioid antagonist to address the problem of itch in atopic dermatitis.
A new, nonsteroidal topical cream for AD called Jakafi (ruxolitinib) may soon hit pharmacy shelves.
Integrative medicine is gaining traction in the health care field, specifically the idea of balancing conventional treatments with complementary therapies for a whole-body approach to treating eczema.
Off-label use of biologic treatments for atopic dermatitis may double the risk for serious infection compared to systemic treatments, researchers found.
The first biologic for treating moderate to severe atopic dermatitis was just approved for teens.
NEA’s product directory is a mobile friendly, searchable database that makes it easier than ever to find personal care products for eczema skin.
A topical treatment containing a common “healthy” skin bacterium was found to reduce AD severity in adults and kids in an early-phase clinical trial.
Honey, L-histidine, East Indian Sandalwood oil, vitamin E and melatonin are among the latest complementary and alternative treatments for eczema undergoing clinical research.
Copyright 2002-2019
National Eczema Association
505 San Marin Drive, #B300
Novato, CA 94945